Skip to main content
×
Home
    • Aa
    • Aa
  • Progress in Neurotherapeutics and Neuropsychopharmacology, Volume 1, Issue 1
  • January 2006, pp. 13-25

Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study

  • Sibel Tekin (a1) and Roger Lane (a1)
  • DOI: http://dx.doi.org/10.1017/S1748232105000030
  • Published online: 01 January 2006
Abstract
Copyright
Corresponding author
Correspondence should be addressed to: Sibel Tekin, MD, Novartis Pharmaceuticals Corporation, One Health Plaza 59 Route 10, East Hanover NJ 07936, USA; Ph: +862 778 4242; Fax: +973 781 6550; Email: sibel.tekin@novartis.com.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Progress in Neurotherapeutics and Neuropsychopharmacology
  • ISSN: 1748-2321
  • EISSN: 1748-233X
  • URL: /core/journals/progress-in-neurotherapeutics-and-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: